Sechenov School
Home › Pharmacology › Combined Oral Contraceptives

Combined Oral Contraceptives

Contraceptiva oralia combinata

For medical students2 min readUpdated 2026-10-10

Combined oral contraceptives are modern pharmaceutical agents containing fixed or varying doses of estrogen and progestin. They provide high contraceptive efficacy alongside a range of important non-contraceptive benefits.

Monophasic preparationsContain a fixed dose of estrogen and progestin in all tablets throughout the cycle.
RegimenThe standard schedule involves 21 days of active pill intake followed by a 7-day pill-free interval.
Cancer protectionLower the risk of endometrial and ovarian cancer due to the action of progestins.
Major limitationSmoking is a strict contraindication due to the high risk of thrombosis.

Classification by Phasing

The rationale for creating multiphasic agents is based on the natural hormonal fluctuations in the female body:

Additional Therapeutic Effects

Beyond preventing unwanted pregnancy, these agents affect various body systems through the specific properties of individual progestins:

  1. Antiandrogenic effect: mediated by cyproterone acetate and dienogest. It helps reduce hirsutism, acne, oily seborrhea, and hair loss. Agents such as Diane-35 and Jeanine are effective in hyperandrogenism, and Jeanine is also used in the management of endometriosis.
  2. Antimineralocorticoid effect: drospirenone in Yasmin blocks fluid retention, preventing edema, breast tenderness, and weight gain.
  3. Cycle regulation and cancer protection: menstrual blood loss is reduced, lowering the risk of anemia and dysmenorrhea. The progestin component protects the endometrium and ovaries by neutralizing the mitogenic effects of estrogens.

Adverse Effects and Hemostasis

COC use may be accompanied by adverse reactions affecting various organ systems:

The primary risk factor is linked to the estrogen component (ethinyl estradiol), which stimulates the synthesis of coagulation factors and increases thrombotic risk. In healthy women, this risk is compensated by the simultaneous activation of the fibrinolytic system. However, in smoking patients, compensatory mechanisms are suppressed, making smoking an absolute contraindication.

Mnemonic

The 21/7 rule: twenty-one days of strict timely dosing, seven days of rest — keeping your cycle under control.

Frequently asked questions

What generations of progestins are used in COCs?

Source materials detail third-generation progestins and mention older progestins.

  • Third-generation progestins — highly selective progestins, including norgestimate, desogestrel, gestodene, dienogest, and drospirenone. They exhibit antiandrogenic properties; modern selective progestins do not adversely affect lipid metabolism. Drospirenone additionally possesses antimineralocorticoid activity.
  • Older progestins — progestins with pronounced androgenic activity, which may cause acne, seborrhea, and hirsutism.

A complete classification of all progestin generations is not detailed in the source.

How should a standard 21-pill pack of COCs be taken?

Intake starts on the first day of the menstrual cycle and continues daily at the same time for 21 days. This is followed by a 7-day break, during which withdrawal bleeding occurs.

Why is smoking a contraindication for COC use?

Ethinyl estradiol promotes blood clotting, and in smoking women, the compensatory activation of fibrinolysis is impaired. This sharply increases the risk of venous and arterial thrombosis.

What causes the antimineralocorticoid effect of Yasmin?

This property is provided by drospirenone, the progestin component. It prevents the sodium and water retention typically provoked by estrogens, protecting against edema and weight gain.

Go deeper

More topics in Pharmacology

Selective Estrogen Receptor ModulatorsRespiratory FluoroquinolonesCiprofloxacin: Mechanism, Spectrum and Clinical UseOfloxacinHormonal ContraceptivesLevofloxacin: Pharmacology, Spectrum and UsesMoxifloxacinProgestin-Only ContraceptivesEmergency ContraceptionTramadol8-Hydroxyquinoline DerivativesHormone Replacement Therapy in MenopausePharmacology →